AFRIN

Brand name authorized in: Brazil Hong Kong Lithuania Poland Singapore

Active ingredients

The drug AFRIN contains one active pharmaceutical ingredient (API):

1 Oxymetazoline
UNII K89MJ0S5VY - OXYMETAZOLINE HYDROCHLORIDE

Oximetazoline is an imidazoline derivative. It exhibits sympathomimetic activity and specifically stimulates the α-adrenergic receptors of the sympathetic system. When administered topically to the nose it causes vasoconstriction of the expansed arterioles of the mucosal nose and a concurrent reduction in blood flow. It also reduces the hypersecretion of the nasal mucosa, ultimately contributing to the decongestion of the nasal mucosa.

Read about Oxymetazoline

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code
Group title
Classification
R01AA05
Oxymetazoline
R Respiratory system → R01 Nasal preparations → R01A Decongestants and other nasal preparations for topical use → R01AA Sympathomimetics, plain
Discover more medicines within R01AA05

Unique identifiers

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country
Identification scheme
Identifier(s)
BR
Câmara de Regulação do Mercado de Medicamentos
Identifier(s): 525516020019117, 525516020019217, 525516020019317, 538917110027917, 538917110028017, 538918020028517
HK
Department of Health Drug Office
Identifier(s): 01416
LT
Valstybinė vaistų kontrolės tarnyba
Identifier(s): 1054106, 1054107, 1054108, 1054109
PL
Rejestru Produktów Leczniczych
Identifier(s): 100003225, 100157537, 100272920, 100272942, 100394214
SG
Health Sciences Authority
Identifier(s): 02656P